In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer

被引：0
|
作者：
Katerin Rojas
Mariona Baliu-Piqué
Aránzazu Manzano
Cristina Saiz-Ladera
Vanesa García-Barberán
Francisco J. Cimas
Pedro Pérez-Segura
Atanasio Pandiella
Balázs Győrffy
Alberto Ocana
机构：
[1] Hospital Clínico San Carlos (HCSC),Experimental Therapeutics Unit, Medical Oncology Department
[2] Instituto de Investigación Sanitaria (IdISSC) and CIBERONC,Translational Research Unit, Translational Oncology Laboratory
[3] Albacete University Hospital,Centro Regional de Investigaciones Biomedicas
[4] Castilla-La Mancha University (CRIB-UCLM),Department of Bioinformatics
[5] Instituto de Biología Molecular y Celular del Cáncer and CIBERONC,2nd Department of Paediatrics
[6] CSIC ,TTK Lendület Cancer Biomarker Research Group
[7] Semmelweis University,undefined
[8] Semmelweis University,undefined
[9] Institute of Enzymology,undefined
来源：
Cellular Oncology | 2021年 / 44卷
关键词：
Breast cancer; Basal-like; HER2+; Tumor biomarkers; Tumor microenvironment; Tumor-infiltrating lymphocytes; Antigen presentation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：569 / 580
页数：11
相关论文
共 50 条
  • [41] BRCAness and PD-L1 expression of basal-like and not basal-like triple negative breast cancer
    Mori, H.
    Kubo, M.
    Yamada, M.
    Kai, M.
    Osako, T.
    Nishimura, R.
    Arima, N.
    Okido, M.
    Kuroki, S.
    Oda, Y.
    Nakamura, M.
    [J]. CANCER RESEARCH, 2016, 76
  • [42] Adjuvant therapy of HER2+ breast cancer
    EP Winer
    [J]. Breast Cancer Research, 11
  • [43] Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
    Kohler, Katharina Theresa
    Goldhammer, Nadine
    Demharter, Samuel
    Pfisterer, Ulrich
    Khodosevich, Konstantin
    Ronnov-Jessen, Lone
    Petersen, Ole William
    Villadsen, Rene
    Kim, Jiyoung
    [J]. NPJ BREAST CANCER, 2022, 8 (01)
  • [44] HER2+ breast cancer: How to evaluate?
    Schmitt F.
    [J]. Advances in Therapy, 2009, 26 (Suppl 1) : S1 - S8
  • [45] Pertuzumab in the Treatment of HER2+ Breast Cancer
    Jhaveri, Komal
    Esteva, Francisco J.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (04): : 591 - 598
  • [46] Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
    Katharina Theresa Kohler
    Nadine Goldhammer
    Samuel Demharter
    Ulrich Pfisterer
    Konstantin Khodosevich
    Lone Rønnov-Jessen
    Ole William Petersen
    René Villadsen
    Jiyoung Kim
    [J]. npj Breast Cancer, 8
  • [47] Genomic, Transcriptomic and Prognostic Caracterisation of Medullary Breast Carcinoma in Comparision With Basal-Like Breast Carcinoma
    Romero, Pierre
    Benhamo, Vanessa
    Berger, Frederique
    Bhalshankar, Jaydutt
    Gruel, Nadege
    Fuhrmann, Laetitia
    McGrogan, Gaetan
    Sastre-Garau, Xavier
    Rouzier, Roman
    Delattre, Olivier
    Vincent-Salomon, Anne
    [J]. MODERN PATHOLOGY, 2015, 28 : 63A - 63A
  • [48] Adjuvant therapy of HER2+ breast cancer
    Winer, E. P.
    [J]. BREAST CANCER RESEARCH, 2009, 11 : S6 - S6
  • [49] Genomic, Transcriptomic and Prognostic Caracterisation of Medullary Breast Carcinoma in Comparision With Basal-Like Breast Carcinoma
    Rumero, Pierre
    Benhamo, Vanessa
    Berger, Frederique
    Bhalshankar, Jaydutt
    Gruel, Nadege
    Fuhrmann, Laetitia
    McGrogan, Gaetan
    Sastre-Garau, Xavier
    Rouzier, Roman
    Delattre, Olivier
    Vincent-Salomon, Anne
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 63A - 63A
  • [50] Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer
    Isnaldi, Edoardo
    Ferraioli, Domenico
    Ferrando, Lorenzo
    Brohee, Sylvain
    Ferrando, Fabio
    Fregatti, Piero
    Bedognetti, Davide
    Ballestrero, Alberto
    Zoppoli, Gabriele
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (02) : 335 - 343
12345